📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
PHARMAIDS PHARMACEUTICALS LTD.PHARMAIDPharmaceuticals
Open
30
High
30.9
Low
29.1
Close
29.95
Volume
2612
Exchange
bse
Time
21-May-2026

Outlook

Score:

1.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofPharmaidsPharmaceuticalsis
Spinning Top
EstimatedStoplossofPharmaidsPharmaceuticalsis
30.9
PharmaidsPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Spinning Top
candlepatternindicatesthetrenddirectionofPharmaidsPharmaceuticalsis
Unpredictableℹ
.

Trend

PharmaidsPharmaceuticalsisin
Sideways trendℹ
.
PriceofPharmaidsPharmaceuticalsis
Downℹ
by

2.44

%.
Target
Buy@

27.52

Sell@

35.68

Current@

29.95

Volume

ThetradevolumesofPharmaidsPharmaceuticalshavebecome
Deficientℹ
ThevolumetrendforPharmaidsPharmaceuticalsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofPharmaidsPharmaceuticalsis

Down

by

81.02

%

Valuation

ThecurrentmarketpriceofPharmaidsPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth119crandtotalassetsworth119cr,thebalancesheetofPharmaidsPharmaceuticalsis:
Balancedℹ
.
Cashflow
PharmaidsPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Upℹ
by

71.43

%.
27.08% i.e. ₹ 13cr spent in operatingℹ
25% i.e. ₹ 12cr spent in investingℹ
47.92% i.e. ₹ 23cr earned in financingℹ
0% in otherℹ
PharmaidsPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 7cr

.Itis
Downℹ
by

158.33

%.
6.21% i.e. ₹ 10cr spent in operatingℹ
45.96% i.e. ₹ 74cr spent in investingℹ
47.83% i.e. ₹ 77cr earned in financingℹ
0% in otherℹ
Income
TheincomeofPharmaidsPharmaceuticalsis

₹ 8cr

and

Loss

is:

₹ 2cr

PharmaidsPharmaceuticalsLossesdecreasedby:

60

%andIncomeisUpby:

33.33

%
TheincomeofPharmaidsPharmaceuticalsis

₹ 6cr

and

Loss

is:

₹ 5cr

PharmaidsPharmaceuticalsLossesincreasedby:

25

%andIncomeisUpby:

50

%
TheincomeofPharmaidsPharmaceuticalsis

₹ 4cr

and

Loss

is:

₹ 4cr

PharmaidsPharmaceuticalsLossesincreasedby:

33.33

%andIncomeisUpby:

0

%
By using this site you agree to the use of cookies to deliver a better site experience.